World News

Measurable Residual Disease Adapted Consolidation Strategy After Quadruplet Induction Therapy for...

Ogkologos - 8 Ιουλίου, 2025

Adding Neoadjuvant and Adjuvant Pembrolizumab to Standard Care Significantly Improves EFS...

Ogkologos - 7 Ιουλίου, 2025

ESMO Call for Stronger Cancer Prevention and Care Mirrored in WHO...

Ogkologos - 4 Ιουλίου, 2025

ESMO Welcomes the European Commission’s Life Sciences Strategy: A Vital Step...

Ogkologos - 4 Ιουλίου, 2025

FDA Approves Taletrectinib for ROS1-positive Non-Small Cell Lung Cancer

Ogkologos - 4 Ιουλίου, 2025

EMA Recommends Granting a Marketing Authorisation for Nirogacestat

Ogkologos - 3 Ιουλίου, 2025

Trastuzumab Deruxtecan Prolongs OS in Second-Line Treatment for Patients with HER2-positive...

Ogkologos - 2 Ιουλίου, 2025

ESMO Calls for Oncology-Specific Safeguards in EU Joint Clinical Assessments of...

Ogkologos - 1 Ιουλίου, 2025

Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with...

Ogkologos - 1 Ιουλίου, 2025

Inavolisib Plus Palbociclib-Fulvestrant Prolongs OS in Patients with PIK3CA-Mutated Advanced Breast Cancer

Ogkologos - 30 Ιουνίου, 2025

1...454647...432 Σελίδα 46 από 432

MOST POPULAR

Texting May Help Reduce Disparities in Colorectal Cancer Screening

19 Μαρτίου, 2021

Patient Guide in Colorectal Cancer Now Available in Bulgarian

18 Φεβρουαρίου, 2026

Ibrutinib-Containing Immunochemotherapy in Front-Line Treatment of Young, Medically Fit Patients with...

14 Μαΐου, 2024

Five Questions with…Fred.

14 Απριλίου, 2022

Φόρτωση περισσοτέρων

Measurable Residual Disease Adapted Consolidation Strategy After Quadruplet Induction Therapy for...

Adding Neoadjuvant and Adjuvant Pembrolizumab to Standard Care Significantly Improves EFS...

ESMO Call for Stronger Cancer Prevention and Care Mirrored in WHO...

ESMO Welcomes the European Commission’s Life Sciences Strategy: A Vital Step...

FDA Approves Taletrectinib for ROS1-positive Non-Small Cell Lung Cancer

EMA Recommends Granting a Marketing Authorisation for Nirogacestat

Trastuzumab Deruxtecan Prolongs OS in Second-Line Treatment for Patients with HER2-positive...

ESMO Calls for Oncology-Specific Safeguards in EU Joint Clinical Assessments of...

Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with...

Inavolisib Plus Palbociclib-Fulvestrant Prolongs OS in Patients with PIK3CA-Mutated Advanced Breast Cancer

MOST POPULAR

Texting May Help Reduce Disparities in Colorectal Cancer Screening

Patient Guide in Colorectal Cancer Now Available in Bulgarian

Ibrutinib-Containing Immunochemotherapy in Front-Line Treatment of Young, Medically Fit Patients with...

Five Questions with…Fred.

HOT NEWS

Cancer Researchers Bring Tools, Experience to COVID-19 Studies

No Improvement in OS or PFS from Sacituzumab Govitecan Compared with...

Trastuzumab Deruxtecan Shows Promising Activity Among Patients with HER2-positive and Signal...

How to Make a Homemade Face Mask from a Folded Scarf—No...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ